Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 2Active not recruiting 1

Sponsor Class

INDUSTRY 5OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3

Conditions

Carcinoma, Non-Small-Cell Lung 21Lung Neoplasms 10Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Skin Neoplasms 6Prostatic Neoplasms 5Neoplasm Metastasis 5Melanoma 5Head and Neck Neoplasms 5Urinary Bladder Neoplasms 4Colorectal Neoplasms 4Carcinoma, Renal Cell 4Carcinoma, Merkel Cell 4Breast Neoplasms 4Sarcoma 3Pancreatic Neoplasms 3Mycosis Fungoides 3Carcinoma, Squamous Cell 3Carcinoma, Hepatocellular 3Carcinoma, Basal Cell 3Adenocarcinoma 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Thyroid Carcinoma, Anaplastic 2Rectal Neoplasms 2Oropharyngeal Neoplasms 2Mouth Neoplasms 2Mesothelioma, Malignant 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2

Interventions

HhAntag691 14Biopsy 8Imiquimod 7Aminolevulinic Acid 7sonidegib 6Tomography, Optical Coherence 6Surgical Procedures, Operative 6Photochemotherapy 6Mohs Surgery 61-phenyl-3,3-dimethyltriazene 6Radiotherapy 5Itraconazole 5Nivolumab 4Microscopy, Confocal 4Curettage 4pembrolizumab 3methyl 5-aminolevulinate 3cemiplimab 3Standard of Care 3Niacinamide 3tazarotene 2relatlimab 2X-Rays 2Watchful Waiting 2Specimen Handling 2Observation 2Magnetic Resonance Spectroscopy 2Laser Therapy 2Gene Expression Profiling 2Eflornithine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Basal Cell × cemiplimab × Clear all
NCT05929664 2026-03-24

Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery

Thomas Jefferson University

Phase 2 Recruiting
70 enrolled
Dermatologic

Carcinoma, Basal Cell

NCT06981325 2026-03-11

CEMI-first

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2 Recruiting
34 enrolled
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

NCT04679480 2024-07-30

Anti-PD1-antibody and Pulsed HHI for Advanced BCC

University of Zurich

Phase 2 Active not recruiting
20 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡